Geert Walther Nygaard
Director Ejecutivo en IBL International GmbH .
Perfil
Geert Walther Nygaard is currently the Co-Managing Director at IBL International GmbH.
Previously, he was the Chief Executive Officer at Glycorex Transplantation AB from 2021 to 2022, and at Epigenomics AG from 2007 to 2010.
He also served as a Director at Abbott GmbH (Germany) in 2012.
Nygaard completed his undergraduate degree at the Technical University of Denmark.
Cargos activos de Geert Walther Nygaard
Empresas | Cargo | Inicio |
---|---|---|
IBL International GmbH
IBL International GmbH Miscellaneous Commercial ServicesCommercial Services IBL International GmbH develops and produces products for the medical-diagnostics laboratories. The company provides research services in the fields of enzyme, radio and luminescence immunoassays. The firm provides products in the diagnostic fields of Endocrinology, Catecholamines, Neuroscience, Tumormarkers, Hypertension, Cytokines, Adhesion Molecules, Autoimmunity, Immunology and Infectious Diseases. IBL International was founded in 1983 and is headquartered in Hamburg, Germany. | Director Ejecutivo | - |
Antiguos cargos conocidos de Geert Walther Nygaard.
Empresas | Cargo | Fin |
---|---|---|
GLYCOREX TRANSPLANTATION AB | Director Ejecutivo | 08/12/2022 |
EPIGENOMICS AG | Presidente | 30/09/2012 |
Abbott GmbH (Germany)
Abbott GmbH (Germany) Pharmaceuticals: MajorHealth Technology Abbott GmbH & Co. KG develops and manufactures health care products. It is engaged in the discovery, development, manufacture, and marketing of pharmaceutical, diagnostic, nutritional, and hospital products. It offers pharmaceutical and diagnostic products ranging from prevention and diagnosis to treatment and cure. The company is headquartered in Ludwigshafen, Germany. | Director/Miembro de la Junta | - |
Formación de Geert Walther Nygaard.
Technical University of Denmark | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
EPIGENOMICS AG | Health Technology |
GLYCOREX TRANSPLANTATION AB | Health Technology |
Empresas privadas | 2 |
---|---|
Abbott GmbH (Germany)
Abbott GmbH (Germany) Pharmaceuticals: MajorHealth Technology Abbott GmbH & Co. KG develops and manufactures health care products. It is engaged in the discovery, development, manufacture, and marketing of pharmaceutical, diagnostic, nutritional, and hospital products. It offers pharmaceutical and diagnostic products ranging from prevention and diagnosis to treatment and cure. The company is headquartered in Ludwigshafen, Germany. | Health Technology |
IBL International GmbH
IBL International GmbH Miscellaneous Commercial ServicesCommercial Services IBL International GmbH develops and produces products for the medical-diagnostics laboratories. The company provides research services in the fields of enzyme, radio and luminescence immunoassays. The firm provides products in the diagnostic fields of Endocrinology, Catecholamines, Neuroscience, Tumormarkers, Hypertension, Cytokines, Adhesion Molecules, Autoimmunity, Immunology and Infectious Diseases. IBL International was founded in 1983 and is headquartered in Hamburg, Germany. | Commercial Services |
- Bolsa de valores
- Insiders
- Geert Walther Nygaard